Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Scherr

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Current Medicinal Chemistry|February 7, 2003
Gene silencing mediated by small interfering RNAs in mammalian cellsMichaela Scherr, Michael A Morgan, Matthias Eder
Cell Cycle (Georgetown, Tex.)|May 8, 2003
Modulation of gene expression by lentiviral-mediated delivery of small interfering RNAMichaela Scherr, Karin Battmer, Arnold Ganser, et al.
Experimental Hematology|October 20, 2009
Quantification of transforming capacity and cooperation of defined genetic alterations in myeloid malignanciesYildirim Dogan, Arnold Ganser, Michaela Scherr, et al.
European Journal of Cell Biology|October 30, 2012
Reduction of STAT3 expression induces mitochondrial dysfunction and autophagy in cardiac HL-1 cellsMyriam Elschami, Michaela Scherr, Brigitte Philippens, et al.
Oligonucleotides|March 6, 2004
Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation modelMichaela Scherr, Karin Battmer, Iris Dallmann, et al.
Haematologica|June 25, 2026
Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemiaLisa Fleischer, Hanna Kirchhoff, Caroline Schoenherr, et al.
Oligonucleotides|April 28, 2007
Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture modelAnuhar Chaturvedi, Karin Battmer, Daniel Schaefer, et al.
Blood|October 24, 2002
Specific inhibition of bcr-abl gene expression by small interfering RNAMichaela Scherr, Karin Battmer, Thomas Winkler, et al.
Genes, Chromosomes & Cancer|November 13, 2004
Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML-M4 cell line (GDM-1)Stefan Nagel, Maren Kaufmann, Michaela Scherr, et al.
Journal of Hematology & Oncology|April 20, 2010
CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulationSonja Röhrs, Michaela Scherr, Julia Romani, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Current Medicinal Chemistry|February 7, 2003
Gene silencing mediated by small interfering RNAs in mammalian cellsMichaela Scherr, Michael A Morgan, Matthias Eder
Cell Cycle (Georgetown, Tex.)|May 8, 2003
Modulation of gene expression by lentiviral-mediated delivery of small interfering RNAMichaela Scherr, Karin Battmer, Arnold Ganser, et al.
Experimental Hematology|October 20, 2009
Quantification of transforming capacity and cooperation of defined genetic alterations in myeloid malignanciesYildirim Dogan, Arnold Ganser, Michaela Scherr, et al.
European Journal of Cell Biology|October 30, 2012
Reduction of STAT3 expression induces mitochondrial dysfunction and autophagy in cardiac HL-1 cellsMyriam Elschami, Michaela Scherr, Brigitte Philippens, et al.
Oligonucleotides|March 6, 2004
Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation modelMichaela Scherr, Karin Battmer, Iris Dallmann, et al.
Haematologica|June 25, 2026
Combining inotuzumab ozogamicin with the p38 inhibitor BIRB 796 and venetoclax exerts synergistic cytotoxicity in B-cell precursor acute lymphoblastic leukemia including very high risk t(17;19) acute lymphoblastic leukemiaLisa Fleischer, Hanna Kirchhoff, Caroline Schoenherr, et al.
Oligonucleotides|April 28, 2007
Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture modelAnuhar Chaturvedi, Karin Battmer, Daniel Schaefer, et al.
Blood|October 24, 2002
Specific inhibition of bcr-abl gene expression by small interfering RNAMichaela Scherr, Karin Battmer, Thomas Winkler, et al.
Genes, Chromosomes & Cancer|November 13, 2004
Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML-M4 cell line (GDM-1)Stefan Nagel, Maren Kaufmann, Michaela Scherr, et al.
Journal of Hematology & Oncology|April 20, 2010
CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulationSonja Röhrs, Michaela Scherr, Julia Romani, et al.
Pageof 9